发明名称 ANNEXINA2 AS IMMUNOLOGICAL TARGET
摘要 AnnexinA2 (ANXA2), a member of the Annexin family of calcium-dependent, phospholipid binding proteins, is one of a panel of identified antigens recognized by the post-vaccination sera of patients who demonstrated prolonged disease-free survival following multiple vaccinations. AnnexinA2 is abundantly expressed in pancreatic adenocarcinomas and cell surface/membrane AnnexinA2 increases with the progression from premalignant lesions to invasive pancreatic adenocarcinomas. The cytoplasmic to cell surface translocation of AnnexinA2 expression is critical for pancreatic cancer cell invasion. In addition, phosphorylation of AnnexinA2 at Tyrosine 23 is important for its localization to the cell surface and for the invasion of pancreatic cancer cells. Finally, loss of AnnexinA2 leads to the loss of the Epithelial-Mesenchymal Transition.
申请公布号 WO2010065613(A2) 申请公布日期 2010.06.10
申请号 WO2009US66374 申请日期 2009.12.02
申请人 THE JOHNS HOPKINS UNIVERSITY;JAFFEE, ELIZABETH MARION;HUANG, LANQING;ZHENG, LEI 发明人 JAFFEE, ELIZABETH MARION;HUANG, LANQING;ZHENG, LEI
分类号 A61K39/395;A61K38/16;A61K38/17;A61P35/00 主分类号 A61K39/395
代理机构 代理人
主权项
地址
您可能感兴趣的专利